Results 301 to 306 of about 146,281 (306)

Outcomes of BCL2-R+ and BCL2-R- Follicular Lymphoma Treatment

Clinical Lymphoma Myeloma and Leukemia
Ekaterina Nesterova, Evgeniy Zvonkov, Alla Kovrigina, Tatiana Obukhova, Yana Mangasarova, Hunan Julhakyan, Sergey Kulikov, Elena Parovichnikova   +7 more
openaire   +1 more source

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer

Cancer Discovery, 2019
Sheau W Lok, James R Whittle, Francois Vaillant   +2 more
exaly  

IBCL-554 Outcomes of BCL2-R+ and BCL2-RFollicular Lymphoma Treatment

Clinical Lymphoma Myeloma and Leukemia
Ekaterina Nesterova, Evgeniy Zvonkov, Alla Kovrigina, Tatiana Obukhova, Yana Mangasarova, Hunan Julhakyan, Sergey Kulikov, Elena Parovichnikova   +7 more
openaire   +1 more source

The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy

Signal Transduction and Targeted Therapy
Meike Vogler, Mike-Andrew Westhoff, Manon Callens   +2 more
exaly  

Phosphorylation of Bcl2 and regulation of apoptosis

Leukemia, 2001
exaly  

[Bcl2-associated X protein].

Bulletin du cancer, 2001
openaire   +1 more source